ANDA 79186, held by Am Regent. Dorzolamide Hydrochloride.
As of Nov 18, 2026, ANDA 79186 (Dorzolamide Hydrochloride), held by Am Regent, was first approved by FDA on Nov 18, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 18, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dorzolamide HydrochlorideEQ 2% BASE · solution/drops;ophthalmic | Dorzolamide Hydrochloride | Discontinued |
| Mar 25, 2020 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 18, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters